Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Jun;5(3):316-29.
doi: 10.1007/s12975-014-0343-0. Epub 2014 Apr 12.

Brain arteriovenous malformation modeling, pathogenesis, and novel therapeutic targets

Affiliations
Free PMC article
Review

Brain arteriovenous malformation modeling, pathogenesis, and novel therapeutic targets

Wanqiu Chen et al. Transl Stroke Res. 2014 Jun.
Free PMC article

Abstract

Patients harboring brain arteriovenous malformation (bAVM) are at life-threatening risk of rupture and intracranial hemorrhage (ICH). The pathogenesis of bAVM has not been completely understood. Current treatment options are invasive, and ≈ 20 % of patients are not offered interventional therapy because of excessive treatment risk. There are no specific medical therapies to treat bAVMs. The lack of validated animal models has been an obstacle for testing hypotheses of bAVM pathogenesis and testing new therapies. In this review, we summarize bAVM model development and bAVM pathogenesis and potential therapeutic targets that have been identified during model development.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest

Wanqiu Chen, Eun-Jung Choi, Cameron M. McDougall and Hua Su declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1. Novel theories of AVM initiation and progression, and new therapeutic targets
EC: endothelial cell; BMDC: bone marrow-derived cells; sFLT: soluble FMS-related tyrosine kinase 1 (sFLT1), also called VEGF receptor-1
Fig. 2
Fig. 2. Development of adult onset brain AVM models
AAV1-VEGF [2×109 viral genome (vg)] is used to stimulate brain focal angiogenesis. Ad-Cre (Ad-Cre/AAV-VEGF/Alk1f/f model), Pdgfb-icreER (pdgfb-icreER/AAV-VEGF/Alk1f/f) and Rosa-CreER (Rosa-CreER/AAV-VEGF/Engf) are used to delete Alk1 or Eng in Alk1f/f or Engf/f mice.
Fig. 3
Fig. 3. Vessel casting showing AVM in the brain angiogenic region
Large tangled vessels resembling bAVM were detected at the injection site of Ad-Cre and AAV-VEGF in the brain of Alk1-floxed mice (black arrow). Bottom images show the enlarged angiogenic foci of the images at the top. Scale bar = 100µm.
Fig. 4
Fig. 4. Adult onset bAVM of Eng2f/2f;R26CreER mice after TM and VEGF treatment
(A) AVM (squared region) in the brain of Eng2f/2f;R26CreER mice 8 weeks after intra-brain injection of AAV-VEGF and intraperitoneal injection of TM. (B) Enlarged image of the AVM lesion. Latex-perfused veins are clearly shown (arrows). Scale bars: 1 mm in (A) and 200 µm in (B).
Fig. 5
Fig. 5. Developmental onset AVMs in the postnatal brain of Eng2f/2f;SM22α-Cre mice
(A) Representative images of latex dye casting show the AVM vessels (squared region) in the brain of 5-week-old Eng2f/2f;SM22α-Cre (B) Enlarged images of dotted boxes shown in (A). Arrows indicate latex-casted veins. Arrow head indicates hemorrhage. Due to the particle size in the latex, the dye enters the vein after intra-left cardiac perfusion only when the A–V shunts are present. Scale bars: 1 mm in (A) and 500 µm in (B).
Fig. 6
Fig. 6. Brain AVM in mice with endothelial-Alk1 deletion and focal VEGF stimulation (Alk1iECKO+VEGF)
AVMs also developed in the intestine, lung and around the ear-tag wound. a: artery: v: vein. Scale bars: 1 mm.

Similar articles

Cited by

References

    1. Young WL. Intracranial arteriovenous malformations: pathophysiology and hemodynamics (Chapter 6) In: Jafar JJ, Awad IA, Rosenwasser RH, editors. Vascular Malformations of the Central Nervous System. New York: Lippincott Williams & Wilkins; 1999. pp. 95–126.
    1. Fleetwood IG, Steinberg GK. Arteriovenous malformations. Lancet. 2002;359(9309):863–873. - PubMed
    1. Arteriovenous Malformation Study Group. Arteriovenous malformations of the brain in adults. N Engl J Med. 1999;340(23):1812–1818. - PubMed
    1. Han PP, Ponce FA, Spetzler RF. Intention-to-treat analysis of Spetzler-Martin grades IV and V arteriovenous malformations: natural history and treatment paradigm. J Neurosurg. 2003;98(1):3–7. - PubMed
    1. Bambakidis NC, Cockroft K, Connolly ES, Amin-Hanjani S, Morcos J, Meyers PM, et al. Preliminary results of the ARUBA sudy. Neurosurgery. 2013;73(2):E379–E381. - PubMed

Publication types

MeSH terms

LinkOut - more resources